Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006161 · ClinicalTrials.gov registry record · Phase 3
Decompression Intervention of Variceal Rebleeding Trial (DIVERT)
A Phase 3 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
- 140
- Enrollment target
NCT00006161 is a Phase 3 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 140 participants.
The verdict
NCT00006161, a Phase 3 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 140 participants
- Enrollment target
Study Summary
The Decompression Intervention of Variceal Rebleeding Trial (DIVERT) is a multi-center prospective randomized clinical trial comparing the radiologic procedure of transjugular intrahepatic portal-systemic shunt (TIPS) with the surgical procedure of distal splenorenal shunt (DSRS) for variceal bleeding in patients with Child's Class A and B cirrhosis. This is recognized nationally and internationally as the study that will answer the question as to which of these is the best treatment for decompression of varices in patients who have failed endoscopic and pharmacologic therapy.
Interventions
- PROCEDURE Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- PROCEDURE Distal Splenorenal Shunt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 1996-12 |
| Est. Completion | 2003-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006161
The ClinicalTrials.gov registry entry for NCT00006161 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transjugular Intrahepatic Portosystemic Shunt (TIPS) is the first listed.
NCT00006161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006161 about?
NCT00006161 is a clinical study titled "Decompression Intervention of Variceal Rebleeding Trial (DIVERT)". The Decompression Intervention of Variceal Rebleeding Trial (DIVERT) is a multi-center prospective randomized clinical trial comparing the radiologic procedure of transjugular intrahepatic portal-systemic shunt (TIPS) with the surgical procedure of distal splenorenal shunt (DSRS) for variceal bleedi...
What is the current status of trial NCT00006161?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 1996-12. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00006161?
The interventions under investigation include: Transjugular Intrahepatic Portosystemic Shunt (TIPS) (PROCEDURE), Distal Splenorenal Shunt (PROCEDURE).
Who is sponsoring clinical trial NCT00006161?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.